Reviva Pharmaceuticals Holdings Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of internally discovered therapies that address unmet medical needs in the areas of central nervous system, respiratory, and metabolic diseases. The company is currently focused on the development of its lead product candidate, RP5063, which targets schizophrenia, bipolar disorder, major depressive disorder, behavioral & psychotic symptoms, dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, and also respiratory indications such as pulmonary arterial hypertension & idiopathic pulmonary fibrosis.
Quote | Reviva Pharmaceuticals Holdings Inc. Warrants (NASDAQ:RVPHW)
Last: | $0.24 |
---|---|
Change Percent: | -20.06% |
Open: | $0.24 |
Close: | $0.24 |
High: | $0.24 |
Low: | $0.24 |
Volume: | 122 |
Last Trade Date Time: | 07/26/2024 03:00:00 am |
News | Reviva Pharmaceuticals Holdings Inc. Warrants (NASDAQ:RVPHW)
2023-09-27 02:48:56 ET Summary Reviva Pharmaceuticals is running a phase 3 study of brilaroxazine in schizophrenia called RECOVER, with results expected in October 2023. A previous phase 2 study showed that brilaroxazine had significant antipsychotic activity, and a potentially di...
Message Board Posts | Reviva Pharmaceuticals Holdings Inc. Warrants (NASDAQ:RVPHW)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Reviva Pharmaceuticals Holdings Inc. Warrants Company Name:
RVPHW Stock Symbol:
NASDAQ Market:
Reviva Pharmaceuticals Holdings Inc. Warrants Website: